Navigation Links
MAP Pharmaceuticals Reports First Quarter of 2011 Financial Results
Date:5/3/2011

ities81117Total liabilities38,90220,138Total stockholders’ equity 82,84062,656Total liabilities and stockholders’ equity $

121,742$

82,794MAP PHARMACEUTICALS, INC.(a development stage enterprise)CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share amounts)(Unaudited)Three Months Ended March 31,20112010Collaboration revenue$

34,162$

-Operating expenses:Research and development 11,5689,786Sales, general and administrative4,8433,881Total operating expenses16,41113,667Income (loss) from operations 17,751(13,667)Other expense, net (147)(391)Net income (loss)$

17,604$

(14,058)Net income (loss) per shareBasic$

0.58$

(0.54)Diluted$

0.56$

(0.54)Weighted average shares outstanding used in calculating net income (loss) per share Basic30,21125,852Diluted31,56025,852
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
3. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
4. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
5. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
6. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
7. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
8. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
9. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
10. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
11. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013 Dr. Sparano is Professor ... Health at the Albert Einstein College of Medicine and ... Montefiore Medical Center. He is also Associate Director ... leads the Einstein Breast Cancer Working Group, a multidisciplinary ... cancer research. He also serves as Vice Chair of ...
(Date:5/17/2013)... rejection occurs when the transplant recipient,s immune system identifies ... It was previously thought that T cells, the immune ... molecules known as chemokines in order to migrate to ... Journal of Clinical Investigation , Fadi Lakkis and colleagues ... that chemokine stimulation of T cells is not required ...
(Date:5/17/2013)... a world-leading provider of scientific, technical and medical information ... recent study in Reproductive BioMedicine Online ... with an abnormal chromosomal composition can be identified by ... thereby classifying the risk of genetic abnormality without a ... undertaken a retrospective study, using their predictive model to ...
(Date:5/17/2013)... USA (PRWEB) May 17, 2013 •    First ... Globes Certified for sustainability ,     New facility will ... , Syngenta unveiled its new ... at the company’s RTP Innovation Center. The first of ... researchers to simulate any agricultural climate and precisely measure ...
Breaking Biology Technology:Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3
... PHILADELPHIA, December 13, The Board of Directors of ... global specialty biopharmaceutical company,today announces its Board succession ... as Non-Executive Chairman; Matthew Emmens (56) will succeed ... appointed Chief,Executive., These Board changes will become ...
... Southern California, Lawrence Berkeley National Laboratory, Pioneers Honored ... ... Biomedical Research, DALLAS, Dec. 13 Susan ... to end breast cancer forever, has announced the,recipients of the ...
... MONTVALE, N.J., Dec. 12 Datascope Corp.,(Nasdaq: ... Co., one of the nation,s,leading independent proxy advisory ... -- James J. Loughlin and William,L. Asmundson -- ... December 20, 2007. To follow Glass Lewis, recommendation,Datascope ...
Cached Biology Technology:Shire plc: Board Changes 2Shire plc: Board Changes 3Shire plc: Board Changes 4Susan G. Komen for the Cure Announces Recipients of 2007 Komen Brinker Award for Scientific Distinction 2Susan G. Komen for the Cure Announces Recipients of 2007 Komen Brinker Award for Scientific Distinction 3Susan G. Komen for the Cure Announces Recipients of 2007 Komen Brinker Award for Scientific Distinction 4Glass Lewis Recommends Datascope Shareholders Vote for Re-Election of the Board's Directors 2Glass Lewis Recommends Datascope Shareholders Vote for Re-Election of the Board's Directors 3Glass Lewis Recommends Datascope Shareholders Vote for Re-Election of the Board's Directors 4Glass Lewis Recommends Datascope Shareholders Vote for Re-Election of the Board's Directors 5Glass Lewis Recommends Datascope Shareholders Vote for Re-Election of the Board's Directors 6Glass Lewis Recommends Datascope Shareholders Vote for Re-Election of the Board's Directors 7
(Date:5/20/2013)... rain forest, popularly known as the lungs of the planet, ... dioxide from the air to grow parts that eventually fall ... the region,s plentiful rainfall. , Until recently people believed ... River and ended up deep in the ocean. University of ... amounts of carbon dioxide though left open the question ...
(Date:5/20/2013)... DIEGO (May 20, 2013) - A novel ... headline the groundbreaking research that will be unveiled at ... Conference (NBC). The meeting takes place Monday, May 20 ... Hotel and Marina. , "The main goal of ... fight against a pathogen that causes the disease", explained ...
(Date:5/19/2013)... A novel study reports that white men and women ... bunions (hallux valgus) and lesser toe deformities, including hammer ... first to estimate the heritability of foot disorders in ... journal published by Wiley on behalf of the American ... that as many as 60% of older adults have ...
Breaking Biology News(10 mins):Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3Germ-fighting vaccine system makes great strides in delivery 2Blame your parents for bunion woes 2
... a failure rate as high as 50 percent, bone ... attempting to repair complex fractures or large areas of ... and cancer. Current synthetic substitutes rarely possess the bone-like ... for surgeons to manipulate in the operating room. In ...
... A University of Illinois study has shown for the ... can be released from its parent compound by bacteria in ... discovery raises the possibility that we will be able to ... broccoli,s cancer-preventive power," said Elizabeth Jeffery, a U of I ...
... 2010 Researchers at the University of Florida Research and ... District have published a report regarding the trends in water ... found in the September-October 2010 Journal of Environmental Quality ... Science Society of America, and the Soil Science Society of ...
Cached Biology News:UMMS biomedical researchers develop more reliable, less expensive synthetic graft material 2UMMS biomedical researchers develop more reliable, less expensive synthetic graft material 3Discovery may help scientists boost broccoli’s cancer-fighting power 2Everglades show improvement in water quality 2
... 8-iso-13,14-dihydro-15-keto Prostaglandin F2α (8-iso-13,14-dihydro-15-keto PGF2α) is ... (8-iso PGF2α), in rabbits, monkeys and ... product of non-specific lipid peroxidation. In ... 8-isoprostane is converted primarily to metabolites ...
... 3C protease from human rhinovirus (HRV 3C) ... brand line of restriction grade proteases. The ... 6XHis-fusion protein, which recognizes the same cleavage ... small, 22 KDa size of the protease, ...
Lyophilized. Purity: ≥90% by electrophoresis. Reconstitute in 0.3% NaCl. Prepared from serum that has been shown by certified tests to be negative for HBsAg and for HIV and HCV antibodies. ...
... DNA Polymerase I Large (Klenow) Fragment, ... that lacks both the 5´→3´ and the ... coli DNA Polymerase I (1,2). It is ... in strand displacement amplification (5). Klenow Fragment, ...
Biology Products: